Search Results - Semiglazov, V.

AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breas... by Gianni, L., Romieu, G., Lichinister, M., Serrano, S., Mansutti, M., Pivot, X., Mariani, P., Andre, F., Chan, Arlene, Lipatov, O., Chan, S., Wardley, A., Greil, R., Moore, N., Prot, S., Pallaud, C., Semiglazov, V.

Get full text

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal,... by Eiermann, W., Pienkowski, T., Crown, J., Sadeghi, S., Chan, Arlene, Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M., Sauter, G., Lindsay, M., Riva, A., Buyse, M., Drevot, P., Taupin, H., Mackey, J.

Get full text

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvan... by Gianni, L., Mansutti, M., Anton, A., Calvo, L., Bisagni, G., Bermejo, B., Semiglazov, V., Thill, M., Chacon, J., Chan, Arlene, Morales, S., Alvarez, I., Plazaola, A., Zambetti, M., Redfern, A., Dittrich, C., Dent, R., Magazzu, D., De Fato, R., Valagussa, P., Tusquets, I.

Get full text

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized tr... by Mackey, J., Pienkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, Arlene, Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M., Sauter, G., Lindsay, M., Houé, V., Buyse, M., Drevot, P., Hitier, S., Bensfia, S., Eiermann, W., Translational Research In Oncology (TRIO)/ Breast Cancer International Research Group (BCIRG)-005 in

Get full text